HomeAI · summaries
Storia in 2 fonti
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence Pharma
Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry into the health and wellness supplements market. This strategic move aims to leverage Fluence's patented technology and dermatologist network to expand Honasa's 'inside-out' beauty solutions. The acquisition is expected to significantly boost Honasa's growth by diversifying its product portfolio into the rapidly expanding Indian nutraceuticals sector.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Honasa Consumer to acquire majority stake in hair therapy brand Fluence Pharma at Rs 135-crore valuation - The Economic Times
Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year,…
- ·
Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence Pharma
Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry into the health and wellness supplements…
- ·
Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition…
- ·
thehindubusinessline.com
Honasa Consumer to acquire 58% stake in Fluence Pharma
In a BSE filing, the company said it will acquire a majority stake via secondary purchase at about ₹135 crores enterprise value and will acquire the remaining 42% in two tranches…
- ·
Honasa shares slip 3% after it announces acquisition of nutraceuticals maker Fluence Pharma
Honasa shares drop 3% after announcing acquisition of Fluence Pharma, despite initial gains and positive long-term market outlook.